Medication Administration and Order-Following Failures
Summary
The facility failed to ensure appropriate delegation of nursing tasks to non-licensed staff by allowing Medication Assistants-Certified (MA-Cs) to administer chemotherapy and other hazardous drugs to multiple residents. Resident 225 had a physician order to start a chemotherapy drug once daily on Monday through Thursday each week, and the MAR showed MA-Cs administered the drug on multiple dates in June and July 2025. Resident 218 had a physician order to start a chemotherapy drug once daily, and the MAR showed the drug was administered by an MA-C on multiple dates in October 2025. Resident 226 had a physician order to start a chemotherapy drug twice daily, and the MAR showed MA-Cs administered the drug repeatedly in December 2025 and January 2026. Resident 171 had a physician order for a hormone therapy drug to treat prostate cancer, and the February 2026 MAR showed an MA-C administered the drug each day for 22 doses. The facility also failed to clarify and follow physician orders for several residents. Resident 7 had orders to elevate the legs while in bed, keep quarter side rails up for self-bed mobility, and ensure shoes were worn when in the wheelchair. However, observations showed the resident sitting in a recliner with no bed in the room, and the resident stated they could not wear shoes because their feet were very swollen. Staff stated the bed was not in the room per the resident’s preference, and that the orders should have been clarified with the provider and not documented as completed when they were not. Resident 8 had an order for an antidepressant twice daily for anxiety disorder and major depressive disorder, but the record also showed the medication was being used for pain, with prior consent forms and a provider note reflecting pain use; staff stated the order should have been clarified and the diagnosis corrected. Resident 205 had PRN pain medication orders with specific pain-score parameters, but the MAR showed an opioid pain medication was given for pain scores outside the ordered range, and staff acknowledged the medication was administered outside the physician’s parameters. The facility further failed to ensure insulin was prepared and administered according to manufacturer instructions. For Resident 206, the manufacturer’s instructions required priming the insulin pen before each use and holding the dose knob during injection for a slow count of five. During observation, one RN did not prime the pen before administration and pressed and immediately released the dose knob, while another RN primed the pen with 0.5 units horizontally and no insulin ejection was observed before administering the ordered dose. Staff stated nurses were expected to prime insulin pens with two units before each administration and hold the dose knob down for five to ten seconds during injection.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.